To go back to the main menu please CLICK HERE
I am currently a GMP Cell-Based Assay Analyst at BioAgilytix. I run regulated and non-regulated cell-based assays, including receptor-binding potency, proliferation, and inhibition assays, across platforms like MSD, ELISA, and qPCR. I follow ALCOA++ data integrity principles and GMP documentation standards, assist in method development and qualification for large-molecule biologics, and work with clients to align study design with regulatory expectations.
At EpiCypher, I adapted CUT&RUN and next-generation sequencing workflows for rare-disease tissue samples and helped establish their tissue and cell culture facility. I authored and implemented over 50 SOPs, supported GLP compliance, and contributed to client project design and execution.
At UNC Chapel Hill's Linnstaedt Lab, I coordinated multiplexed omics projects spanning LC-MS proteomics and RNA-seq within a human trauma-recovery cohort. I managed timelines across cross-functional teams, maintained data quality, and contributed to analyses linking acute biomarkers to white matter integrity and recovery outcomes after injury. This work resulted in co-authorship on several peer-reviewed publications, including a 2025 Journal of Neurotrauma paper and a 2026 Science Immunology study on sex differences in pain duration.
Earlier, at NC State's Plants for Human Health Institute, I ran wound-healing and toxicity assays with plant-derived compounds in human dermal fibroblasts and murine macrophages, and authored SOPs that helped standardize daily lab operations. That process pushed me to think seriously about reproducibility and documentation, well before I entered formally regulated environments.
My graduate work at the University of Rochester, where I earned my M.Sc. in Microbiology and Immunology, gave me a strong foundation in experimental design. In the Morrell Lab, I developed flow-cytometry workflows to isolate murine stem cells and studied how platelets connect innate and adaptive immunity. In the Ritchlin Lab, I validated preclinical targets in psoriatic arthritis models, including the G-protein DC-STAMP. As a post-baccalaureate researcher, I also worked on Xenopus models to study T-cell biology and nonclassical MHC class I-dependent invariant T cells.
My scientific career started in Puerto Rico, where I joined Dr. Juan Carlos Martinez-Cruzado's Laboratory of Genomic Diversity at UPR-Mayagüez. We built a DNA repository to map local polymorphisms, trained students in molecular methods and bioinformatics, and worked closely with our community. That early combination of field context and bench work shaped how I still think about research.
Sim, J., O'Guin, E., Sugimoto, C., Laumet, S., Monahan, K., Bernard, M. P., McLean, S. A., Albertorio-Sáez, L. M., Zhao, Y., Ramakrishnan, H., de Souza, S., Eller, O. C., Smoyer, C. J., Baumbauer, K. M., Mack, M., Folger, J. K., Robison, A. J., Linnstaedt, S. D., & Laumet, G. (2026). Monocyte-derived IL-10 drives sex differences in pain duration. Science Immunology, 11(116). https://doi.org/10.1126/sciimmunol.adx0292
Jeong, J., Hausmann, S., Dong, H., Szczepski, K., Flores, N. M., Garcia Gonzalez, A., Shi, L., Lu, X., Lempiäinen, J., Jakab, M., Zeng, L., Chasan, T., Bareke, E., Dong, R., Carlson, E., Padilla, R., Husmann, D., Thompson, J., Shipman, G. A., Zahn, E., Barnes, C. A., Khan, L. F., Albertorio-Sáez, L. M., Brill, E., Kumary, V. U. S., Marunde, M. R., Maryanski, D. N., Szany, C. C., Venters, B. J., Windham, C. L., Nowakowski, M. E., Czaban, I., Jaremko, M., Keogh, M.-C., Le, K., Soth, M. J., Garcia, B. A., Jaremko, Ł., Majewski, J., Mazur, P. K., & Gozani, O. (2025). NSD2 inhibitors rewire chromatin to treat lung and pancreatic cancers. Nature, 649(8095), 205–215. https://doi.org/10.1038/s41586-025-09299-y
For a complete list, please refer to my ORCID record: https://orcid.org/my-orcid?orcid=0000-0003-3419-5849
<aside> 💡
Copyrighted 2025-present Liz Albertorio and Thinkerleaf Science Outreach LLC. All rights reserved. Page last updated: 13May26
</aside>